Clinical Trial Update: Avatrombopag for HCC Patients With Thrombocytopenia Who Intend to Undergo TACE and/or HAIC [Phase 2]

View source ↗

Summary

Phase 2 trial investigating avatrombopag for thrombocytopenia in hepatocellular carcinoma patients planned for transarterial chemoembolization (TACE) or hepatic…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• Avatrombopag (avatrombopag)

Snippet

Sponsor: Second Affiliated Hospital of Guangzhou Medical University | Conditions: Thrombocytopenia, Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN